These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34437553)

  • 1. Importance of attributes and willingness to pay for oral anticoagulant therapy in patients with atrial fibrillation in China: A discrete choice experiment.
    Zhao J; Wang H; Li X; Hu Y; Yan VKC; Wong CKH; Guo Y; Cheung MKH; Lip GYH; Siu CW; Tse HF; Chan EW
    PLoS Med; 2021 Aug; 18(8):e1003730. PubMed ID: 34437553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physician and Patient Preferences for Nonvalvular Atrial Fibrillation Therapies.
    Shafrin J; Bruno A; MacEwan JP; Campinha-Bacote A; Trocio J; Shah M; Tan W; Romley JA
    Value Health; 2016 Jun; 19(4):451-9. PubMed ID: 27325337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferences for oral anticoagulants in atrial fibrillation: a best-best discrete choice experiment.
    Ghijben P; Lancsar E; Zavarsek S
    Pharmacoeconomics; 2014 Nov; 32(11):1115-27. PubMed ID: 25027944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients' preferences and willingness-to-pay for disease-modifying therapies.
    Frost N; Freeman J; Brixner D; Mort J; Clem J; Ngorsuraches S
    Mult Scler Relat Disord; 2019 Oct; 35():55-60. PubMed ID: 31323483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the Preferences and Willingness-to-Pay for Oral Antidiabetic Drugs Among Patients with Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment.
    Chuang LH; Zhang H; Hong T; Xie S
    Patient; 2024 Sep; 17(5):565-574. PubMed ID: 38642244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients' preferences in anticoagulant therapy: discrete choice experiment.
    Najafzadeh M; Gagne JJ; Choudhry NK; Polinski JM; Avorn J; Schneeweiss SS
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):912-9. PubMed ID: 25387782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis.
    van Walraven C; Hart RG; Singer DE; Laupacis A; Connolly S; Petersen P; Koudstaal PJ; Chang Y; Hellemons B
    JAMA; 2002 Nov; 288(19):2441-8. PubMed ID: 12435257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferences for anticoagulation therapy in atrial fibrillation: the patients' view.
    Böttger B; Thate-Waschke IM; Bauersachs R; Kohlmann T; Wilke T
    J Thromb Thrombolysis; 2015 Nov; 40(4):406-15. PubMed ID: 26260625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial fibrillation patient preferences for oral anticoagulation and stroke knowledge: Results of a conjoint analysis.
    Lane DA; Meyerhoff J; Rohner U; Lip GYH
    Clin Cardiol; 2018 Jun; 41(6):855-861. PubMed ID: 29696664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status and factors influencing oral anticoagulant therapy among patients with non-valvular atrial fibrillation in Jiangsu province, China: a multi-center, cross-sectional study.
    Liu T; Yang HL; Gu L; Hui J; Omorogieva O; Ren MX; Wang XH
    BMC Cardiovasc Disord; 2020 Jan; 20(1):22. PubMed ID: 31948390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Trends in Guideline-Based Oral Anticoagulant Prescription for Patients With Ischemic Stroke and Atrial Fibrillation in China.
    Gu HQ; Yang X; Wang CJ; Zhao XQ; Wang YL; Liu LP; Meng X; Jiang Y; Li H; Liu C; Xiong YY; Fonarow GC; Wang D; Xian Y; Li ZX; Wang YJ
    JAMA Netw Open; 2021 Jul; 4(7):e2118816. PubMed ID: 34323982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Country-based Comparison of Atrial Fibrillation Patients' Preferences for Oral Anticoagulation: An Evaluation of Discrete Choice Experiments in Five Different Countries.
    Henry M; Wosnitza M; Thate-Waschke IM; Bauersachs R; Ueng KC; Chang KC; Wilke T
    J Cardiovasc Pharmacol; 2021 Jan; 77(1):100-106. PubMed ID: 33165142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
    Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
    Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.
    Ruff CT; Giugliano RP; Braunwald E; Hoffman EB; Deenadayalu N; Ezekowitz MD; Camm AJ; Weitz JI; Lewis BS; Parkhomenko A; Yamashita T; Antman EM
    Lancet; 2014 Mar; 383(9921):955-62. PubMed ID: 24315724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anticoagulation status and adherence in patients with atrial fibrillation hospitalized for ACS and the impact on 1-year prognosis: a multicenter cohort study].
    Zhu LY; Li Q; Yu LY; Liu Y; Chen YN; Wang Z; Zhang SY; Li J; Liu Y; Zhao YL; Xi Y; Pi L; Sun YH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Jul; 51(7):731-741. PubMed ID: 37460427
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessing patient preferences for switching from warfarin to direct oral anticoagulants.
    Wright JN; Vazquez SR; Kim K; Jones AE; Witt DM
    J Thromb Thrombolysis; 2019 Nov; 48(4):596-602. PubMed ID: 31273515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity in Preferences for Anti-coagulant Use in Atrial Fibrillation: A Latent Class Analysis.
    van Til J; Oudshoorn-Groothuis C; Weernink M; von Birgelen C
    Patient; 2020 Aug; 13(4):445-455. PubMed ID: 32329020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks.
    Aguilar MI; Hart R; Pearce LA
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006186. PubMed ID: 17636831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants.
    Lip GYH; Murphy RR; Sahiar F; Ingall TJ; Dhamane AD; Ferri M; Hlavacek P; Preib MT; Keshishian A; Russ C; Rosenblatt L; Yuce H; Deitelzweig S
    JAMA Netw Open; 2022 Aug; 5(8):e2229333. PubMed ID: 36044214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient preferences for osteoporosis in Spain: a discrete choice experiment.
    Darbà J; Restovic G; Kaskens L; Balbona MA; Carbonell A; Cavero P; Jordana M; Prieto C; Molina A; Padró I
    Osteoporos Int; 2011 Jun; 22(6):1947-54. PubMed ID: 20838770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.